Cancer Cell International (Jul 2004)

Dendritic cell-based immunotherapy of hormone refractory prostate carcinoma (HRPCa) – a pilot trial

  • Unger C,
  • Leo R,
  • Constantiniu O,
  • Stoll C,
  • Sauer B,
  • Langenkamp A,
  • Hildenbrand B,
  • Azemar M

DOI
https://doi.org/10.1186/1475-2867-4-S1-S39
Journal volume & issue
Vol. 4, no. Suppl 1
p. S39

Abstract

Read online

No abstracts available.